Image de couverture de livre

Correcting for Missing Data When Evaluating Surrogate Markers in a Clinical Trial

Fuente: arXiv

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Lotspeich, Sarah C., Nguyen, P. D. Anh., Parast, Layla
Format:	Preprint
Publié:	2026
Sujets:	Methodology Applications
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

RISE: Two-Stage Rank-Based Identification of High-Dimensional Surrogate Markers Applied to Vaccinology
par: Hughes, Arthur, et autres
Publié: (2025)

Robust Evaluation of Longitudinal Surrogate Markers with Censored Data
par: Agniel, Denis, et autres
Publié: (2024)

A Bayesian Critique of Rank-Based Methods for Surrogate Marker Evaluation
par: Carlotti, Pietro, et autres
Publié: (2026)

Two-phase validation sampling via principal components to improve efficiency in multi-model estimation from error-prone biomedical databases
par: Lotspeich, Sarah C., et autres
Publié: (2025)

Group Sequential Testing of a Treatment Effect Using a Surrogate Marker
par: Parast, Layla, et autres
Publié: (2024)

On Using Large Language Models to Enhance Clinically-Driven Missing Data Recovery Algorithms in Electronic Health Records
par: Lotspeich, Sarah C., et autres
Publié: (2025)

Bias in Meta-Analytic Modeling of Surrogate Endpoints in Cancer Screening Trials
par: Long, James P., et autres
Publié: (2025)

Meta-Analysis of High-Dimensional Surrogate Markers
par: Hughes, Arthur, et autres
Publié: (2026)

Symmetric Vaccine Efficacy
par: McGowan, Lucy D'Agostino, et autres
Publié: (2025)

The `Why' behind including `Y' in your imputation model
par: McGowan, Lucy D'Agostino, et autres
Publié: (2023)

A Causal Framework for Evaluating Jointly Longitudinal Outcomes and Surrogate Markers: A State-Space Approach
par: Santos Jr., Silvaneo V. dos, et autres
Publié: (2026)

Accounting for Heavy Censoring in Evaluating the Risk Stratification Abilities of Existing Models for Time to Diagnosis of Huntington Disease
par: Grosser, Kyle F., et autres
Publié: (2025)

Quantifying the HIV reservoir with dilution assays and deep viral sequencing
par: Lotspeich, Sarah C., et autres
Publié: (2023)

Efficient Testing Using Surrogate Information
par: Knowlton, Rebecca, et autres
Publié: (2025)

Assessing Surrogate Heterogeneity in Real World Data Using Meta-Learners
par: Knowlton, Rebecca, et autres
Publié: (2025)

Evaluating the Surrogate Index as a Decision-Making Tool Using 200 A/B Tests at Netflix
par: Zhang, Vickie, et autres
Publié: (2023)

A Functional-Class Meta-Analytic Framework for Quantifying Surrogate Resilience
par: Hsiao, Emily, et autres
Publié: (2026)

Evaluation of Surrogate Endpoints Based on Meta-Analysis with Surrogate Indices
par: Stijven, Florian, et autres
Publié: (2025)

Toward Valid Generative Clinical Trial Data with Survival Endpoints
par: Chassat, Perrine, et autres
Publié: (2025)

Resilience Measures for the Surrogate Paradox
par: Hsiao, Emily, et autres
Publié: (2025)

Adjusting for Selection Bias Due to Missing Eligibility Criteria in Emulated Target Trials
par: Benz, Luke, et autres
Publié: (2024)

Semiparametric Joint Modeling to Estimate the Treatment Effect on a Longitudinal Surrogate with Application to Chronic Kidney Disease Trials
par: Wang, Xuan, et autres
Publié: (2024)

A Workflow for Evaluating Regional Treatment Effect Heterogeneity in Multi-Regional Clinical Trials
par: Zhang, Cong, et autres
Publié: (2026)

A Comparative Evaluation of a Conditional Median-Based Bayesian Growth Curve Modeling Approach with Missing Data
par: Tang, Dandan, et autres
Publié: (2025)

Overcoming data challenges through enriched validation and targeted sampling to measure whole-person health in electronic health records
par: Lotspeich, Sarah C., et autres
Publié: (2025)

A Bayesian Discrete Framework for Enhancing Decision-Making Processes in Clinical Trial Designs and Evaluations
par: Pramanik, Paramahansa, et autres
Publié: (2026)

Model-free Approach to Evaluate a Censored Intermediate Outcome as a Surrogate for Overall Survival
par: Wang, Xuan, et autres
Publié: (2024)

Analysis of Linked Files: A Missing Data Perspective
par: Kamat, Gauri, et autres
Publié: (2024)

Imputation of Nonignorable Missing Data in Surveys Using Auxiliary Margins Via Hot Deck and Sequential Imputation
par: Yang, Yanjiao, et autres
Publié: (2024)

Cumulative Logit Ordinal Regression with Proportional Odds under Nonignorable Missing Response -- Application to Phase III Trial
par: Maity, Arnab Kumar, et autres
Publié: (2025)

Statistical Inference for Heterogeneous Treatment Effect with Right-censored Data from Synthesizing Randomized Clinical Trials and Real-world Data
par: Mao, Guangcai, et autres
Publié: (2025)

Establishing the Parallels and Differences Between Right-Censored and Missing Covariates
par: Vazquez, Jesus E., et autres
Publié: (2024)

On the Calibration of Bayesian Success Criteria and Operating Characteristics for Clinical Trials
par: Yang, Peng, et autres
Publié: (2026)

[Invited Discussion] Randomization Tests to Address Disruptions in Clinical Trials: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions
par: Phillips, Rachael V., et autres
Publié: (2024)

Accounting for Missing Data in Public Health Research Using a Synthesis of Statistical and Mathematical Models
par: Zivich, Paul N, et autres
Publié: (2025)

Generalizing Trimming Bounds for Endogenously Missing Outcome Data Using Random Forests
par: Samii, Cyrus, et autres
Publié: (2023)

E-values for Adaptive Clinical Trials: Anytime-Valid Monitoring in Practice
par: Sokolova, Alexandra, et autres
Publié: (2026)

Heterogeneous Clinical Trial Outcomes via Multi-Output Gaussian Processes
par: Thomas, Owen, et autres
Publié: (2024)

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials
par: Maity, Arnab Kumar, et autres
Publié: (2024)

Inverse Probability Weighting of Count Exposures in the Presence of Missing Data: A Simulation Study
par: Danka, Martin N., et autres
Publié: (2026)